Eptacog Alfa
ATC B02BD08 · 6 markets · 20 records
AU 5 records · 5 strengths
- 2 mginjectionNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe
- 1 mginjectionNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe
- 5 mginjectionNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe
- 8 mginjectionNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 4 records · 4 strengths
- 2 mginjectionNOVOSEVEN 2 mg (100 KUI), poudre et solvant pour solution injectable
- 1 mginjectionNOVOSEVEN 1 mg (50 KUI), poudre et solvant pour solution injectable
- 5 mginjectionNOVOSEVEN 5 mg (250 KUI), poudre et solvant pour solution injectable
- 8 mginjectionNOVOSEVEN 8 mg (400 KUI), poudre et solvant pour solution injectable
ES 3 records · 3 strengths
- 2 mginjectionNOVOSEVEN KUI)
- 1 mginjectionNOVOSEVEN KUI)
- 5 mginjectionNOVOSEVEN KUI)
SG 2 records · 2 strengths
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | AU | SG | ES | TW | HK | FR |
|---|---|---|---|---|---|---|
| 2 mg injection | NOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe | NovoSeven® powder and solvent for solution for injection 1mg | NOVOSEVEN KUI) | NOVOSEVEN 2 mg (100 KUI), poudre et solvant pour solution injectable | ||
| 1 mg injection | NOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe | NovoSeven® powder and solvent for solution for injection 1mg | NOVOSEVEN KUI) | NOVOSEVEN 1 mg (50 KUI), poudre et solvant pour solution injectable | ||
| 5 mg injection | NOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe | NOVOSEVEN KUI) | NOVOSEVEN 5 mg (250 KUI), poudre et solvant pour solution injectable | |||
| 8 mg injection | NOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe | NOVOSEVEN 8 mg (400 KUI), poudre et solvant pour solution injectable | ||||
injection | NovoSeven RT 諾和第七因子室溫注射劑 | |||||
unknown | NovoSeven RT | NOVOSEVEN POWDER AND SOLVENT FOR INJ 1MG |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.